Patient Guide: Phase I/II clinical trial of CDX-1140 in combination with 6MHP+mBRAF vaccine and poly-ICLC in high-risk melanoma (NCT04364230)

We'll Help You Connect with This Trial

Quri.ai is a free clinical trial matching service. We help patients like you connect directly with research sites conducting this study.

  • Get matched to the right study location for you
  • Connect directly with study coordinators at multiple participating sites
  • Understand eligibility with our simplified screening tool
  • Free service - we're here to help you access clinical research
Trial ID: NCTNCT04364230
Status: COMPLETED_NEXT_PHASE_UPCOMING
Condition: Melanoma
Phase: PHASE1, PHASE2

Loading interactive enrollment tools...

The full interactive experience will load momentarily